Global Endoparasiticide Market Growth 2020-2025
According to this study, over the next five years the Endoparasiticide market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Endoparasiticide business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Endoparasiticide market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Endoparasiticide, covering the supply chain analysis, impact assessment to the Endoparasiticide market size growth rate in several scenarios, and the measures to be undertaken by Endoparasiticide companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Ear Tags
Tablets
Injectables
Feed Additives
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Veterinary Hospitals or Clinics
Animal Farms
Home Care Settings
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Boehringer Ingelheim
Vetoquinol
Elanco
Merck
Virbac
Zoetis
Bayer AG
Novartis AG
Eli Lilly
Ceva Sante Animlae
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Endoparasiticide consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Endoparasiticide market by identifying its various subsegments.
Focuses on the key global Endoparasiticide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Endoparasiticide with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Endoparasiticide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Endoparasiticide Consumption 2015-2025
2.1.2 Endoparasiticide Consumption CAGR by Region
2.2 Endoparasiticide Segment by Type
2.2.1 Ear Tags
2.2.2 Tablets
2.2.3 Injectables
2.2.4 Feed Additives
2.3 Endoparasiticide Consumption by Type
2.3.1 Global Endoparasiticide Consumption Market Share by Type (2015-2020)
2.3.2 Global Endoparasiticide Revenue and Market Share by Type (2015-2020)
2.3.3 Global Endoparasiticide Sale Price by Type (2015-2020)
2.4 Endoparasiticide Segment by Application
2.4.1 Veterinary Hospitals or Clinics
2.4.2 Animal Farms
2.4.3 Home Care Settings
2.5 Endoparasiticide Consumption by Application
2.5.1 Global Endoparasiticide Consumption Market Share by Type (2015-2020)
2.5.2 Global Endoparasiticide Value and Market Share by Type (2015-2020)
2.5.3 Global Endoparasiticide Sale Price by Type (2015-2020)
3 Global Endoparasiticide by Company
3.1 Global Endoparasiticide Sales Market Share by Company
3.1.1 Global Endoparasiticide Sales by Company (2018-2020)
3.1.2 Global Endoparasiticide Sales Market Share by Company (2018-2020)
3.2 Global Endoparasiticide Revenue Market Share by Company
3.2.1 Global Endoparasiticide Revenue by Company (2018-2020)
3.2.2 Global Endoparasiticide Revenue Market Share by Company (2018-2020)
3.3 Global Endoparasiticide Sale Price by Company
3.4 Global Endoparasiticide Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Endoparasiticide Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Endoparasiticide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Endoparasiticide by Regions
4.1 Endoparasiticide by Regions
4.2 Americas Endoparasiticide Consumption Growth
4.3 APAC Endoparasiticide Consumption Growth
4.4 Europe Endoparasiticide Consumption Growth
4.5 Middle East & Africa Endoparasiticide Consumption Growth
5 Americas
5.1 Americas Endoparasiticide Consumption by Countries
5.1.1 Americas Endoparasiticide Consumption by Countries (2015-2020)
5.1.2 Americas Endoparasiticide Value by Countries (2015-2020)
5.2 Americas Endoparasiticide Consumption by Type
5.3 Americas Endoparasiticide Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Endoparasiticide Consumption by Regions
6.1.1 APAC Endoparasiticide Consumption by Regions (2015-2020)
6.1.2 APAC Endoparasiticide Value by Regions (2015-2020)
6.2 APAC Endoparasiticide Consumption by Type
6.3 APAC Endoparasiticide Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Endoparasiticide by Countries
7.1.1 Europe Endoparasiticide Consumption by Countries (2015-2020)
7.1.2 Europe Endoparasiticide Value by Countries (2015-2020)
7.2 Europe Endoparasiticide Consumption by Type
7.3 Europe Endoparasiticide Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Endoparasiticide by Countries
8.1.1 Middle East & Africa Endoparasiticide Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Endoparasiticide Value by Countries (2015-2020)
8.2 Middle East & Africa Endoparasiticide Consumption by Type
8.3 Middle East & Africa Endoparasiticide Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Endoparasiticide Distributors
10.3 Endoparasiticide Customer
11 Global Endoparasiticide Market Forecast
11.1 Global Endoparasiticide Consumption Forecast (2021-2025)
11.2 Global Endoparasiticide Forecast by Regions
11.2.1 Global Endoparasiticide Forecast by Regions (2021-2025)
11.2.2 Global Endoparasiticide Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Endoparasiticide Forecast by Type
11.8 Global Endoparasiticide Forecast by Application
12 Key Players Analysis
12.1 Boehringer Ingelheim
12.1.1 Company Information
12.1.2 Endoparasiticide Product Offered
12.1.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Boehringer Ingelheim Latest Developments
12.2 Vetoquinol
12.2.1 Company Information
12.2.2 Endoparasiticide Product Offered
12.2.3 Vetoquinol Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Vetoquinol Latest Developments
12.3 Elanco
12.3.1 Company Information
12.3.2 Endoparasiticide Product Offered
12.3.3 Elanco Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Elanco Latest Developments
12.4 Merck
12.4.1 Company Information
12.4.2 Endoparasiticide Product Offered
12.4.3 Merck Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Merck Latest Developments
12.5 Virbac
12.5.1 Company Information
12.5.2 Endoparasiticide Product Offered
12.5.3 Virbac Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Virbac Latest Developments
12.6 Zoetis
12.6.1 Company Information
12.6.2 Endoparasiticide Product Offered
12.6.3 Zoetis Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Zoetis Latest Developments
12.7 Bayer AG
12.7.1 Company Information
12.7.2 Endoparasiticide Product Offered
12.7.3 Bayer AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Bayer AG Latest Developments
12.8 Novartis AG
12.8.1 Company Information
12.8.2 Endoparasiticide Product Offered
12.8.3 Novartis AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novartis AG Latest Developments
12.9 Eli Lilly
12.9.1 Company Information
12.9.2 Endoparasiticide Product Offered
12.9.3 Eli Lilly Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Eli Lilly Latest Developments
12.10 Ceva Sante Animlae
12.10.1 Company Information
12.10.2 Endoparasiticide Product Offered
12.10.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Ceva Sante Animlae Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Endoparasiticide Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Ear Tags
Table 5. Major Players of Tablets
Table 6. Major Players of Injectables
Table 7. Major Players of Feed Additives
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Endoparasiticide Consumption Market Share by Type (2015-2020)
Table 10. Global Endoparasiticide Revenue by Type (2015-2020) ($ million)
Table 11. Global Endoparasiticide Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Endoparasiticide Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Endoparasiticide Consumption Market Share by Application (2015-2020)
Table 15. Global Endoparasiticide Value by Application (2015-2020)
Table 16. Global Endoparasiticide Value Market Share by Application (2015-2020)
Table 17. Global Endoparasiticide Sale Price by Application (2015-2020)
Table 18. Global Endoparasiticide Sales by Company (2017-2019) (K Units)
Table 19. Global Endoparasiticide Sales Market Share by Company (2017-2019)
Table 20. Global Endoparasiticide Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Endoparasiticide Revenue Market Share by Company (2017-2019)
Table 22. Global Endoparasiticide Sale Price by Company (2017-2019)
Table 23. Global Endoparasiticide Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Endoparasiticide Products Offered
Table 25. Endoparasiticide Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Endoparasiticide Consumption by Regions 2015-2020 (K Units)
Table 27. Global Endoparasiticide Consumption Market Share by Regions 2015-2020
Table 28. Global Endoparasiticide Value by Regions 2015-2020 ($ Millions)
Table 29. Global Endoparasiticide Value Market Share by Regions 2015-2020
Table 30. Americas Endoparasiticide Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Endoparasiticide Consumption Market Share by Countries (2015-2020)
Table 32. Americas Endoparasiticide Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Endoparasiticide Value Market Share by Countries (2015-2020)
Table 34. Americas Endoparasiticide Consumption by Type (2015-2020) (K Units)
Table 35. Americas Endoparasiticide Consumption Market Share by Type (2015-2020)
Table 36. Americas Endoparasiticide Consumption by Application (2015-2020) (K Units)
Table 37. Americas Endoparasiticide Consumption Market Share by Application (2015-2020)
Table 38. APAC Endoparasiticide Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Endoparasiticide Consumption Market Share by Countries (2015-2020)
Table 40. APAC Endoparasiticide Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Endoparasiticide Value Market Share by Regions (2015-2020)
Table 42. APAC Endoparasiticide Consumption by Type (2015-2020) (K Units)
Table 43. APAC Endoparasiticide Consumption Market Share by Type (2015-2020)
Table 44. APAC Endoparasiticide Consumption by Application (2015-2020) (K Units)
Table 45. APAC Endoparasiticide Consumption Market Share by Application (2015-2020)
Table 46. Europe Endoparasiticide Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Endoparasiticide Consumption Market Share by Countries (2015-2020)
Table 48. Europe Endoparasiticide Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Endoparasiticide Value Market Share by Countries (2015-2020)
Table 50. Europe Endoparasiticide Consumption by Type (2015-2020) (K Units)
Table 51. Europe Endoparasiticide Consumption Market Share by Type (2015-2020)
Table 52. Europe Endoparasiticide Consumption by Application (2015-2020) (K Units)
Table 53. Europe Endoparasiticide Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Endoparasiticide Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Endoparasiticide Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Endoparasiticide Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Endoparasiticide Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Endoparasiticide Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Endoparasiticide Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Endoparasiticide Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Endoparasiticide Consumption Market Share by Application (2015-2020)
Table 62. Endoparasiticide Distributors List
Table 63. Endoparasiticide Customer List
Table 64. Global Endoparasiticide Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Endoparasiticide Consumption Market Forecast by Regions
Table 66. Global Endoparasiticide Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Endoparasiticide Value Market Share Forecast by Regions
Table 68. Global Endoparasiticide Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Endoparasiticide Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Endoparasiticide Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Endoparasiticide Value Market Share Forecast by Type (2021-2025)
Table 72. Global Endoparasiticide Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Endoparasiticide Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Endoparasiticide Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Endoparasiticide Value Market Share Forecast by Application (2021-2025)
Table 76. Boehringer Ingelheim Product Offered
Table 77. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Boehringer Ingelheim Main Business
Table 79. Boehringer Ingelheim Latest Developments
Table 80. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 81. Vetoquinol Product Offered
Table 82. Vetoquinol Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Vetoquinol Main Business
Table 84. Vetoquinol Latest Developments
Table 85. Vetoquinol Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 86. Elanco Product Offered
Table 87. Elanco Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Elanco Main Business
Table 89. Elanco Latest Developments
Table 90. Elanco Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Product Offered
Table 92. Merck Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Merck Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 96. Virbac Product Offered
Table 97. Virbac Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Virbac Main Business
Table 99. Virbac Latest Developments
Table 100. Virbac Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 101. Zoetis Product Offered
Table 102. Zoetis Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Zoetis Main Business
Table 104. Zoetis Latest Developments
Table 105. Zoetis Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 106. Bayer AG Product Offered
Table 107. Bayer AG Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 108. Bayer AG Main Business
Table 109. Bayer AG Latest Developments
Table 110. Bayer AG Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Novartis AG Product Offered
Table 112. Novartis AG Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Novartis AG Main Business
Table 114. Novartis AG Latest Developments
Table 115. Novartis AG Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 116. Eli Lilly Product Offered
Table 117. Eli Lilly Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Eli Lilly Main Business
Table 119. Eli Lilly Latest Developments
Table 120. Eli Lilly Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 121. Ceva Sante Animlae Product Offered
Table 122. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. Ceva Sante Animlae Main Business
Table 124. Ceva Sante Animlae Latest Developments
Table 125. Ceva Sante Animlae Basic Information, Company Total Revenue (in $ million), Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Endoparasiticide
Figure 2. Endoparasiticide Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Endoparasiticide Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Endoparasiticide Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Ear Tags
Figure 7. Product Picture of Tablets
Figure 8. Product Picture of Injectables
Figure 9. Product Picture of Feed Additives
Figure 10. Global Endoparasiticide Consumption Market Share by Type (2015-2020)
Figure 11. Global Endoparasiticide Value Market Share by Type (2015-2020)
Figure 12. Endoparasiticide Consumed in Veterinary Hospitals or Clinics
Figure 13. Global Endoparasiticide Market: Veterinary Hospitals or Clinics (2015-2020) (K Units)
Figure 14. Global Endoparasiticide Market: Veterinary Hospitals or Clinics (2015-2020) ($ Millions)
Figure 15. Endoparasiticide Consumed in Animal Farms
Figure 16. Global Endoparasiticide Market: Animal Farms (2015-2020) (K Units)
Figure 17. Global Endoparasiticide Market: Animal Farms (2015-2020) ($ Millions)
Figure 18. Endoparasiticide Consumed in Home Care Settings
Figure 19. Global Endoparasiticide Market: Home Care Settings (2015-2020) (K Units)
Figure 20. Global Endoparasiticide Market: Home Care Settings (2015-2020) ($ Millions)
Figure 21. Global Endoparasiticide Consumption Market Share by Application (2015-2020)
Figure 22. Global Endoparasiticide Value Market Share by Application (2015-2020)
Figure 23. Global Endoparasiticide Sales Market Share by Company in 2017
Figure 24. Global Endoparasiticide Sales Market Share by Company in 2019
Figure 25. Global Endoparasiticide Revenue Market Share by Company in 2017
Figure 26. Global Endoparasiticide Revenue Market Share by Company in 2019
Figure 27. Global Endoparasiticide Sale Price by Company in 2019
Figure 28. Global Endoparasiticide Consumption Market Share by Regions 2015-2020
Figure 29. Global Endoparasiticide Value Market Share by Regions 2015-2020
Figure 30. Americas Endoparasiticide Consumption 2015-2020 (K Units)
Figure 31. Americas Endoparasiticide Value 2015-2020 ($ Millions)
Figure 32. APAC Endoparasiticide Consumption 2015-2020 (K Units)
Figure 33. APAC Endoparasiticide Value 2015-2020 ($ Millions)
Figure 34. Europe Endoparasiticide Consumption 2015-2020 (K Units)
Figure 35. Europe Endoparasiticide Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Endoparasiticide Consumption 2015-2020 (K Units)
Figure 37. Middle East & Africa Endoparasiticide Value 2015-2020 ($ Millions)
Figure 38. Americas Endoparasiticide Consumption Market Share by Countries in 2019
Figure 39. Americas Endoparasiticide Value Market Share by Countries in 2019
Figure 40. Americas Endoparasiticide Consumption Market Share by Type in 2019
Figure 41. Americas Endoparasiticide Consumption Market Share by Application in 2019
Figure 42. United States Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 43. United States Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 45. Canada Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 47. Mexico Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Endoparasiticide Consumption Market Share by Countries in 2019
Figure 49. APAC Endoparasiticide Value Market Share by Regions in 2019
Figure 50. APAC Endoparasiticide Consumption Market Share by Type in 2019
Figure 51. APAC Endoparasiticide Consumption Market Share by Application in 2019
Figure 52. China Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 53. China Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 55. Japan Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 57. Korea Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 59. Southeast Asia Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 60. India Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 61. India Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 63. Australia Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Endoparasiticide Consumption Market Share by Countries in 2019
Figure 65. Europe Endoparasiticide Value Market Share by Countries in 2019
Figure 66. Europe Endoparasiticide Consumption Market Share by Type in 2019
Figure 67. Europe Endoparasiticide Consumption Market Share by Application in 2019
Figure 68. Germany Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 69. Germany Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 70. France Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 71. France Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 72. UK Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 73. UK Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 75. Italy Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 77. Russia Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Endoparasiticide Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Endoparasiticide Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Endoparasiticide Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Endoparasiticide Consumption Market Share by Application in 2019
Figure 82. Egypt Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 83. Egypt Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 85. South Africa Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 87. Israel Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 89. Turkey Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Endoparasiticide Consumption Growth 2015-2020 (K Units)
Figure 91. GCC Countries Endoparasiticide Value Growth 2015-2020 ($ Millions)
Figure 92. Global Endoparasiticide Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 93. Global Endoparasiticide Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Endoparasiticide Consumption 2021-2025 (K Units)
Figure 95. Americas Endoparasiticide Value 2021-2025 ($ Millions)
Figure 96. APAC Endoparasiticide Consumption 2021-2025 (K Units)
Figure 97. APAC Endoparasiticide Value 2021-2025 ($ Millions)
Figure 98. Europe Endoparasiticide Consumption 2021-2025 (K Units)
Figure 99. Europe Endoparasiticide Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Endoparasiticide Consumption 2021-2025 (K Units)
Figure 101. Middle East & Africa Endoparasiticide Value 2021-2025 ($ Millions)
Figure 102. United States Endoparasiticide Consumption 2021-2025 (K Units)
Figure 103. United States Endoparasiticide Value 2021-2025 ($ Millions)
Figure 104. Canada Endoparasiticide Consumption 2021-2025 (K Units)
Figure 105. Canada Endoparasiticide Value 2021-2025 ($ Millions)
Figure 106. Mexico Endoparasiticide Consumption 2021-2025 (K Units)
Figure 107. Mexico Endoparasiticide Value 2021-2025 ($ Millions)
Figure 108. Brazil Endoparasiticide Consumption 2021-2025 (K Units)
Figure 109. Brazil Endoparasiticide Value 2021-2025 ($ Millions)
Figure 110. China Endoparasiticide Consumption 2021-2025 (K Units)
Figure 111. China Endoparasiticide Value 2021-2025 ($ Millions)
Figure 112. Japan Endoparasiticide Consumption 2021-2025 (K Units)
Figure 113. Japan Endoparasiticide Value 2021-2025 ($ Millions)
Figure 114. Korea Endoparasiticide Consumption 2021-2025 (K Units)
Figure 115. Korea Endoparasiticide Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Endoparasiticide Consumption 2021-2025 (K Units)
Figure 117. Southeast Asia Endoparasiticide Value 2021-2025 ($ Millions)
Figure 118. India Endoparasiticide Consumption 2021-2025 (K Units)
Figure 119. India Endoparasiticide Value 2021-2025 ($ Millions)
Figure 120. Australia Endoparasiticide Consumption 2021-2025 (K Units)
Figure 121. Australia Endoparasiticide Value 2021-2025 ($ Millions)
Figure 122. Germany Endoparasiticide Consumption 2021-2025 (K Units)
Figure 123. Germany Endoparasiticide Value 2021-2025 ($ Millions)
Figure 124. France Endoparasiticide Consumption 2021-2025 (K Units)
Figure 125. France Endoparasiticide Value 2021-2025 ($ Millions)
Figure 126. UK Endoparasiticide Consumption 2021-2025 (K Units)
Figure 127. UK Endoparasiticide Value 2021-2025 ($ Millions)
Figure 128. Italy Endoparasiticide Consumption 2021-2025 (K Units)
Figure 129. Italy Endoparasiticide Value 2021-2025 ($ Millions)
Figure 130. Russia Endoparasiticide Consumption 2021-2025 (K Units)
Figure 131. Russia Endoparasiticide Value 2021-2025 ($ Millions)
Figure 132. Spain Endoparasiticide Consumption 2021-2025 (K Units)
Figure 133. Spain Endoparasiticide Value 2021-2025 ($ Millions)
Figure 134. Egypt Endoparasiticide Consumption 2021-2025 (K Units)
Figure 135. Egypt Endoparasiticide Value 2021-2025 ($ Millions)
Figure 136. South Africa Endoparasiticide Consumption 2021-2025 (K Units)
Figure 137. South Africa Endoparasiticide Value 2021-2025 ($ Millions)
Figure 138. Israel Endoparasiticide Consumption 2021-2025 (K Units)
Figure 139. Israel Endoparasiticide Value 2021-2025 ($ Millions)
Figure 140. Turkey Endoparasiticide Consumption 2021-2025 (K Units)
Figure 141. Turkey Endoparasiticide Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Endoparasiticide Consumption 2021-2025 (K Units)
Figure 143. GCC Countries Endoparasiticide Value 2021-2025 ($ Millions)
Figure 144. Boehringer Ingelheim Endoparasiticide Market Share (2018-2020)
Figure 145. Vetoquinol Endoparasiticide Market Share (2018-2020)
Figure 146. Elanco Endoparasiticide Market Share (2018-2020)
Figure 147. Merck Endoparasiticide Market Share (2018-2020)
Figure 148. Virbac Endoparasiticide Market Share (2018-2020)
Figure 149. Zoetis Endoparasiticide Market Share (2018-2020)
Figure 150. Bayer AG Endoparasiticide Market Share (2018-2020)
Figure 151. Novartis AG Endoparasiticide Market Share (2018-2020)
Figure 152. Eli Lilly Endoparasiticide Market Share (2018-2020)
Figure 153. Ceva Sante Animlae Endoparasiticide Market Share (2018-2020)
